Santhera Pharmaceuticals Holding AG’s Share Placement And Debt Financing

Homburger has advised Santhera Pharmaceuticals Holding AG in its Share Placement and Debt Financing.

Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had raised new liquid funds of up to CHF 22.1 million through a private placement of an aggregate of 500,000 new shares (resulting in gross proceeds of CHF 7.1 million), and earlier through a syndicated credit line facility in the amount of up to CHF 15 million.

Homburger acted as legal and tax counsel to Santhera with a team led by partner Dieter Gericke (Corporate | M&A, in picture) and comprised partner Jürg Frick, counsel Eduard De Zordi (both Banking and Finance), partner Stefan Oesterhelt (Tax), associates Daniel Häusermann and Lorenzo Togni (both Corporate | M&A), as well as associate Simone Gloor and junior associate Kristof Reber (both Banking and Finance).

Involved fees earner: Eduard De Zordi – Homburger; Jürg Frick – Homburger; Dieter Gericke – Homburger; Simone Gloor – Homburger; Daniel Häusermann – Homburger; Stefan Oesterhelt – Homburger; Kristof Reber – Homburger; Lorenzo Togni – Homburger;

Law Firms: Homburger;

Clients: Santhera Pharmaceuticals;